Comparison of Allows Measurement of Cardiac Output Between Clearsight System and Transpulmonary Thermodilution

Comparaison de Mesure de débit Cardiaque Entre système Clearsight® et Thermodilution Transpulmonaire.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02728791

Acronym

CONDUCT

Enrollment

Registered

2016-04-05

Start date

2016-05-10

Completion date

2018-07-25

Last updated

2026-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Output, Low, Shock

Brief summary

Correlation study between the data provided by two measurement systems, trans- pulmonary thermodilution and ClearSight © (non invasive), to determine the interest in routine use (cardiac output, cardiac index, stroke volume and blood pressure).

Detailed description

Since 2014, Edwards society has developed a completely non-invasive monitoring device for measurement of blood pressure and continuous cardiac output without inserting foreign intravascular bodies in the patient. Initially tested on healthy volunteers cardiac disease -free, the correlation with the other devices seems to be good. If this ClearSight © system show a relevant accuracy in measuring blood pressure and cardiac output with a specific ICU hospitalized population, it could justify its place in the therapeutic arsenal of monitoring in intensive care. This is a common care ,prospective observational single center study , concerning the results of blood pressure , cardiac output values and their variations.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* age\>18 * hospitalized in surgical ICU, with hemodynamic instability or vaso-active drugs * No opposition formulated

Exclusion criteria

* Impossibility of establishment of one of the cardiac output measurement devices * Pregnant woman * Refuse to participate

Design outcomes

Primary

Measure	Time frame
Comparison of values and changes in cardiac index between the two devices	2 days

Secondary

Measure	Time frame
Comparison of values and variations in mean arterial pressure between the two devices	2 days
Comparison of values and variations in mean cardiac output between the two devices	2 days
Comparison of values and variations in mean stroke volume variation between the two devices	2 days

Countries

France

Contacts

PRINCIPAL_INVESTIGATOROlivier HUET

CHU de Brest

Outcome results